← All organizations

Avistone Biotechnology Co., Ltd.

For profit

Also known as: Avistone Biotechnology Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 30, 2026

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 12 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

ans03

Recent trials (13)

NCT07285148CollaboratorPhase 1/Phase 2Jun 30, 2026
NCT06970782Lead sponsorPhase 3May 15, 2025
NCT06716138Lead sponsorPhase 1Mar 1, 2025
NCT06827145CollaboratorPhase 2Oct 14, 2024
NCT06574347Lead sponsorPhase 2Aug 7, 2024
NCT06307795Lead sponsorPhase 1Apr 20, 2024
NCT06281964Lead sponsorPhase 3Mar 30, 2024
NCT06328439Lead sponsorPhase 1Mar 19, 2024
NCT06046495Study directorPhase 1Nov 29, 2023
NCT06046495Lead sponsorPhase 1Nov 29, 2023
NCT06015503Lead sponsorPhase 2Jul 21, 2023
NCT06343064Lead sponsorPhase 1/Phase 2Jun 13, 2023
NCT05347628Lead sponsorPhase 1Aug 25, 2020

Details

Founded: Beijing, CN
Last known activity: Jun 30, 2026